EFB Dengue Literature Review

Bcl-6

6 min read

Bcl-6

Overview

Bcl-6 (B cell lymphoma 6) is a zinc-finger transcriptional repressor essential for germinal center (GC) formation. It is the master transcription factor of both GC B cells and GC-type T follicular helper (TFH) cells. Bcl-6 expression is required for B cells to enter and persist within GCs, and for CD4⁺ T cells to differentiate into the Bcl-6⁺ CXCR5⁺ GC-TFH cells that sustain GC reactions. Its absence or suppression therefore provides a direct readout of GC disruption.

In the context of this wiki, Bcl-6 is the critical marker linking GC failure to EF pathway dominance: loss of Bcl-6⁺ cells indicates that the GC arm of humoral immunity is compromised, forcing B cell responses through the extrafollicular pathway.

Key Points from Literature

  • Bcl-6⁺ GC B cells strikingly reduced in COVID-19 LNs and spleens: Multi-color immunofluorescence of post-mortem thoracic lymph nodes showed marked reduction in CD19⁺Bcl-6⁺ cells (p<0.001 vs. non-COVID controls). Splenic Bcl-6⁺ B cells were similarly reduced (p<0.01). This was evident from the earliest disease timepoint (<10 days from symptom onset) and persisted through late disease (see Kaneko2020 - GC Loss and TFH Block in COVID-19, n=11 COVID + 6 LN controls + 7 spleen controls, multi-color immunofluorescence).

  • AID⁺ B cells preserved despite Bcl-6⁺ B cell loss: AID-expressing B cells were maintained in COVID-19 LNs and spleens, though diffusely distributed rather than concentrated in GC structures. This dissociation — Bcl-6 lost but AID preserved — demonstrates that B cell activation and class switch recombination continue extrafollicularly even when GC formation is abrogated (see Kaneko2020 - GC Loss and TFH Block in COVID-19).

  • Bcl-6⁺ GC-TFH cells specifically depleted: The most striking T cell finding was the near-absence of CD4⁺Bcl-6⁺ GC-type TFH cells in both LNs (p<0.001) and spleens (p<0.01) of COVID-19 patients. CD4⁺CXCR5⁺ pre-GC TFH cells were present but reduced; CD4⁺ICOS⁺ TFH cells were diminished. The selective loss of Bcl-6⁺ TFH cells indicates a specific block in the final step of GC-TFH differentiation — the transition from pre-GC (Bcl-6⁻CXCR5⁺) to GC-type (Bcl-6⁺CXCR5⁺) TFH (see Kaneko2020 - GC Loss and TFH Block in COVID-19).

  • Bcl-6⁺ T follicular regulatory cells also absent: Multispectral imaging with CD4/CXCR5/FOXP3/Bcl-6 showed no overlap between Bcl-6 and FOXP3 expression in COVID-19 secondary lymphoid organs, indicating the near-absence of Bcl-6⁺ T follicular regulatory cells alongside the loss of Bcl-6⁺ TFH and GC B cells (see Kaneko2020 - GC Loss and TFH Block in COVID-19).

  • DN1 cells are Bcl-6-pathway associated: DN1 cells (CXCR5⁺, CD21⁺) share a near-identical transcriptome with switched memory cells and express TCF7, CXCR5, and BACH2 — hallmarks of GC transit. They contrast with DN2 cells (CXCR5⁻, T-bet⁺), which belong to the EF pathway. CD40L stimulation does not inhibit DN1 generation, consistent with GC compatibility (see Jenks2018 - DN2 B Cells and EF Pathway in SLE, RNA-seq + in vitro differentiation).

  • GC loss in COVID-19 also observed peripherally in Woodruff2020: The peripheral blood EF dominance in critically ill COVID-19 patients — expanded DN2, aN, ASC populations with germline-dominant BCR repertoires — is the blood-level correlate of the tissue-level GC loss demonstrated by Kaneko2020 (see Woodruff2020 - EF B Cell Responses in COVID-19, 24-marker spectral FCM, n=10 ICU).

  • ★ BCL6 is not required for memory B cell generation — only for the GC route to it. Mice lacking BCL6 in the haematopoietic compartment, and patients with CD40L deficiency, are both unable to form functional germinal centers yet still generate detectable memory B cell populations (see Glaros2025 - Multilayered Identity of B Cell Memory, review, no original data). Early antigen-specific, largely unswitched cells with a memory phenotype appear before the first GC B cells form, and early memory B cell formation is not affected by BCL6 deficiency. See Early Memory B Cell.

  • Low or absent BCL6 defines the tripotent pre-GC precursor. Activated precursors at the T–B border express intermediate IRF4 and exhibit absent or low BCL6, distinguishing them from committed GC B cells; BCL6 is the key transcriptional regulator of GC B cell fate and its upregulation marks GC commitment (see Glaros2025 - Multilayered Identity of B Cell Memory, review).

  • BCL6 sits at the centre of the GC-derived memory exit circuit. BCL6 represses Bcl2, so escaping BCL6 repression is required for the pro-survival programme of GC-derived memory; HHEX was proposed to promote memory generation precisely by downregulating BCL6 and thereby releasing BCL6-mediated repression of BCL2. IL-4-mediated BCL6 downregulation may likewise facilitate GC exit. Transient removal of anti-CD40 antibody in vitro was sufficient to induce BCL6 upregulation, and reduced T-derived signals in vivo increased the propensity to generate GC B cells — suggesting interruptions in CD40–CD40L signalling, rather than signal strength per se, may bias toward the GC lineage (see Glaros2025 - Multilayered Identity of B Cell Memory, review, mouse).

  • ★ Bcl-6 is required in the T cell but dispensable in the B cell for the T-bet⁺CD11c⁺ response — the clearest statement of that division in the wiki. CD4^Cre^Bcl6^fl/fl^ mice (Tfh-deficient) showed decreased percentages and numbers of T-bet⁺CD11c⁺ B cells with little reduction in Th1 cells. Conversely, a mixed bone marrow chimera (50% CD19^Cre^Bcl6^fl/fl^ : 50% CD19^Cre^Bcl6^+/+^) left germinal centres dominated by Bcl6-sufficient cells (~5:1) while the T-bet⁺CD11c⁺ compartment was populated ~1:1 by Bcl6-deficient cells — B-cell-intrinsic Bcl6 is not needed. Bcl6 was also among the GC signature genes downregulated in sorted T-bet⁺CD11c⁺ cells, and the result held in influenza PR8 as well as LCMV (see Song2022 - Tfh Outside Germinal Centers Drive T-bet CD11c B Cells, mouse, n=3–5 mice/group).

Contradictions & Debates

  • Whether Bcl-6⁺ TFH cells are generated in milder COVID-19 is unknown — the tissue study was limited to fatal cases. Milder disease may represent a continuum with some GC formation.
  • The absence of Bcl-6 in COVID-19 lymphoid tissue contrasts with dengue, where elevated CXCL13 suggests possible GC activity (though CXCL13 is not GC-specific). Whether dengue produces Bcl-6⁺ TFH cells — and whether severe dengue suppresses them — is untested.

Germinal Center, Extrafollicular Response, AID, CXCR5, ICOS, T-bet, TNF-alpha, Double-Negative B Cell, DN2 B Cell, Memory B Cell, Early Memory B Cell, BACH2, Germinal Center

Sources

Graph View

Backlinks